Joseph Amprey
Oprichter bij Zero Point Five Therapeutics, Inc.
Profiel
Joseph L.
Amprey was the founder of Symbiomix Therapeutics LLC, which was founded in 2012, where he held the title of Chief Business Officer from 2012 to 2018.
Dr. Amprey is also the founder of Zyngenia, Inc., Zero Point Five Therapeutics, Inc. Dr. Amprey's former jobs include Senior Managing Director at MedImmune Ventures, Inc. from 2002 to 2010, and Director at Adheron Therapeutics, Inc., Melinta Subsidiary Corp., and NKT Therapeutics, Inc. Dr. Amprey received his undergraduate degree from the University of Pennsylvania and his doctorate from Cornell University.
Actieve functies van Joseph Amprey
| Bedrijven | Functie | Begin |
|---|---|---|
Zero Point Five Therapeutics, Inc.
 Zero Point Five Therapeutics, Inc. BiotechnologyHealth Technology Zero Point Five Therapeutics, Inc. is a drug development company that focuses on neglected tropical diseases and soil-transmitted helminthiasis. The company is based in Baltimore, MD. The company was founded by Helen S. Pentikis, Joseph L. Amprey. Joseph L. Amprey has been the CEO since incorporation. | Oprichter | - |
Eerdere bekende functies van Joseph Amprey
| Bedrijven | Functie | Einde |
|---|---|---|
Symbiomix Therapeutics LLC
 Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Oprichter | 01-10-2018 |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Private Equity Investor | 30-03-2010 |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Directeur/Bestuurslid | 17-09-2009 |
NKT Therapeutics, Inc.
 NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA. | Directeur/Bestuurslid | - |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Oprichter | - |
Opleiding van Joseph Amprey
| University of Pennsylvania | Undergraduate Degree |
| Cornell University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Finance |
Adheron Therapeutics, Inc.
 Adheron Therapeutics, Inc. BiotechnologyHealth Technology Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA. | Health Technology |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Retail Trade |
NKT Therapeutics, Inc.
NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA. | Health Technology |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Health Technology |
Zero Point Five Therapeutics, Inc.
Zero Point Five Therapeutics, Inc. BiotechnologyHealth Technology Zero Point Five Therapeutics, Inc. is a drug development company that focuses on neglected tropical diseases and soil-transmitted helminthiasis. The company is based in Baltimore, MD. The company was founded by Helen S. Pentikis, Joseph L. Amprey. Joseph L. Amprey has been the CEO since incorporation. | Health Technology |
